Study Links 340b Increase To Hospital Acquisition Of Physician Practices


Last Thursday the Berkeley Research Group released a study attributing a sharp increase in the 340B drug discount program to the fact that hospitals across the country are acquiring physician-based oncology practices.

The 340B program requires pharmaceutical manufacturers with Medicaid-covered products to give discounts on covered drugs purchased by eligible entities, which include disproportionate share hospitals, critical access hospitals and children’s hospitals.  The study found that when hospitals acquired oncology practices, their 340B purchase volume grew at three times the rate of hospitals that didn’t acquire practices.  The study indicated that the volume of charity care provided by those hospitals did not appear to have increased correspondingly.

The Biotechnology Industry Organization, which funded the study, cited the findings as evidence that some hospitals are using the 340B program to increase their bottom line rather than serve the underprivileged, as intended by the program.

Safety net hospitals don’t agree.  The trade group Safety Net Hospitals for Pharmaceutical Access responded with a statement that “big pharma has purchased another study.”


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Faegre Baker Daniels | Attorney Advertising

Written by:


Faegre Baker Daniels on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.